摘要 |
<p>The use of agonists or antagonists of Mullerian Inhibiting Substance to suppress or treat respiratory distress syndrome. The treatment can be accomplished by providing an effective amount of the agonist or antagonist to a neonatal or prenatal individual.</p> |